Sep 29, 2020 / 08:30PM GMT
Operator
Welcome to the Regeneron Pharmaceuticals COVID-19 Antibody Program Update Conference Call. My name is Gigi, and I will be your operator for today's call. (Operator Instructions)
Please note that this conference is being recorded. I will now turn the call over to Justin Holko, Vice President, Investor Relations. You may begin.
Justin Holko - Regeneron Pharmaceuticals, Inc. - VP of IR
Thank you, Gigi, and welcome to everybody listening to our webcast as we provide an update on the Regeneron COVID-19 Antibody Program. Joining me today are Dr. Len Schleifer, Founder, President and Chief Executive Officer; Dr. George Yancopoulos, Co-Founder, President and Chief Scientific Officer; Dr. David Weinreich, Senior Vice President, Head of Clinical Development; Dr. Christos Kyratsous, Vice President, Infectious Diseases and Viral Vector Technologies; and Hala Mirza, Senior Vice President, Corporate Communications and Citizenship.
After our prepared remarks on the accompanying slides, which can be found on our website, we will open the call for Q&A from
Regeneron Pharmaceuticals Inc COVID-19 Program Update Transcript
Sep 30, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers